Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hannah Fassel"'
Autor:
Katherine A. Hajjar, Mary M. Ruisi, Maria T. DeSancho, Neha Kumar, Huigen Chen, Hannah Fassel
Publikováno v:
Blood. 137:2221-2230
Reduced plasma fibrinolysis has been identified as a potential risk factor for venous thromboembolism (VTE), but the role of cell surface fibrinolysis in VTE is unknown. The annexin A2/S100A10 complex serves as a coreceptor for plasminogen and tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c921e0668723b241024010dfbb3b8b
https://doi.org/10.1182/blood.2020008123
https://doi.org/10.1182/blood.2020008123
Publikováno v:
Blood. 140:10760-10760
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dba903ec6378590be541e52c0ff3bb70
https://doi.org/10.1182/blood-2022-162287
https://doi.org/10.1182/blood-2022-162287
Autor:
Catherine E. McGuinn, Hannah Fassel
Publikováno v:
Br J Haematol
Haemophilia is an inherited bleeding disorder in which the haemostatic defect results from deficiency of coagulation factor VIII (FVIII) in haemophilia A or factor IX (FIX) in haemophilia B. Traditional treatments for haemophilia have largely worked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b3f0c69d5fc7cc303cd908a14d4165
https://pubmed.ncbi.nlm.nih.gov/34340257
https://pubmed.ncbi.nlm.nih.gov/34340257
Autor:
Sujit Sheth, Hannah Fassel
Publikováno v:
The Indian Journal of Pediatrics. 87:141-149
Bone marrow failure has many different etiologies, including genetic defects which manifest with specific syndromes, as well as acquired conditions as a result of insults to the bone marrow leading to aplasia. The clinical picture is varied and clues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7d007dde83f0c1a6c0c64cb9bca1aa
https://doi.org/10.1007/s12098-019-03066-4
https://doi.org/10.1007/s12098-019-03066-4
Publikováno v:
Journal of Pediatric Hematology/Oncology. 38:563-569
Despite the advances in oncology, the survival of children with Ewing Sarcoma metastatic at diagnosis continues to be 27% 3-year event-free survival and 34% 3-year overall survival. In other words, 7 of 10 children die within 3 years of their initial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449a92e155d2f6adf0c9f47a9965e4e7
https://doi.org/10.1097/mph.0000000000000616
https://doi.org/10.1097/mph.0000000000000616
Publikováno v:
J Pediatr Hematol Oncol
Thrombocytopenia, a serious complication of myelosuppressive chemotherapy in cancer patients, is managed with platelet transfusions until recovery of platelet counts. However, children receiving chemotherapy can rarely develop immune thrombocytopenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ccce56b1089f306a998aafafdde4b6
https://pubmed.ncbi.nlm.nih.gov/29683946
https://pubmed.ncbi.nlm.nih.gov/29683946
Publikováno v:
Blood. 134:443-443
Introduction: Recent evidence indicates that plasma hypofibrinolysis, as measured by clot lysis times (CLT) at or above the 90th percentile, can double the risk of venous thromboembolism (VTE). To our knowledge, there are no studies on the role of ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4840011dc6d13ee75e83ebb0b21b7af5
https://doi.org/10.1182/blood-2019-127426
https://doi.org/10.1182/blood-2019-127426